Surgery for high-risk localized prostate cancer.

Standard

Surgery for high-risk localized prostate cancer. / Schmitges, Jan; Trinh, Quoc-Dien; Walz, Jochen; Graefen, Markus.

In: Ther Adv Urol, Vol. 3, No. 4, 4, 2011, p. 173-182.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Schmitges, J, Trinh, Q-D, Walz, J & Graefen, M 2011, 'Surgery for high-risk localized prostate cancer.', Ther Adv Urol, vol. 3, no. 4, 4, pp. 173-182. <http://www.ncbi.nlm.nih.gov/pubmed/21969847?dopt=Citation>

APA

Schmitges, J., Trinh, Q-D., Walz, J., & Graefen, M. (2011). Surgery for high-risk localized prostate cancer. Ther Adv Urol, 3(4), 173-182. [4]. http://www.ncbi.nlm.nih.gov/pubmed/21969847?dopt=Citation

Vancouver

Schmitges J, Trinh Q-D, Walz J, Graefen M. Surgery for high-risk localized prostate cancer. Ther Adv Urol. 2011;3(4):173-182. 4.

Bibtex

@article{10c3b20c8f3b479e9bfb2bd7f90bcc33,
title = "Surgery for high-risk localized prostate cancer.",
abstract = "Treatment of men with high-risk prostate cancer (PCa) remains challenging for urologists. The complex natural history of high-risk PCa and the lack of specific and accurate definitions for high-risk disease impede treatment decision making. Historically, surgery in this patient group has been avoided based on the perception of ostensibly higher complication rates associated with inferior functional and oncological outcomes. To date, no randomized data comparing different therapy approaches have been made available. Several investigators have reported that continence rates in patients after radical prostatectomy (RP) for high-risk disease seem to be unaffected. Similarly, in a large proportion of these men, a nerve-sparing procedure can be performed without a significant negative impact on surgical margin rates and with comparable potency results. Moreover, extended pelvic lymph node dissection (EPLND) contributes to accurate pathological staging with a marginal effect on perioperative morbidity. With regards to the benefits of RP on local recurrence and cure rates, realistic expectations regarding the success of RP alone or in the context of a multimodal approach should be provided during patient counseling.",
author = "Jan Schmitges and Quoc-Dien Trinh and Jochen Walz and Markus Graefen",
year = "2011",
language = "English",
volume = "3",
pages = "173--182",
journal = "Ther Adv Urol",
issn = "1756-2872",
publisher = "SAGE Publications",
number = "4",

}

RIS

TY - JOUR

T1 - Surgery for high-risk localized prostate cancer.

AU - Schmitges, Jan

AU - Trinh, Quoc-Dien

AU - Walz, Jochen

AU - Graefen, Markus

PY - 2011

Y1 - 2011

N2 - Treatment of men with high-risk prostate cancer (PCa) remains challenging for urologists. The complex natural history of high-risk PCa and the lack of specific and accurate definitions for high-risk disease impede treatment decision making. Historically, surgery in this patient group has been avoided based on the perception of ostensibly higher complication rates associated with inferior functional and oncological outcomes. To date, no randomized data comparing different therapy approaches have been made available. Several investigators have reported that continence rates in patients after radical prostatectomy (RP) for high-risk disease seem to be unaffected. Similarly, in a large proportion of these men, a nerve-sparing procedure can be performed without a significant negative impact on surgical margin rates and with comparable potency results. Moreover, extended pelvic lymph node dissection (EPLND) contributes to accurate pathological staging with a marginal effect on perioperative morbidity. With regards to the benefits of RP on local recurrence and cure rates, realistic expectations regarding the success of RP alone or in the context of a multimodal approach should be provided during patient counseling.

AB - Treatment of men with high-risk prostate cancer (PCa) remains challenging for urologists. The complex natural history of high-risk PCa and the lack of specific and accurate definitions for high-risk disease impede treatment decision making. Historically, surgery in this patient group has been avoided based on the perception of ostensibly higher complication rates associated with inferior functional and oncological outcomes. To date, no randomized data comparing different therapy approaches have been made available. Several investigators have reported that continence rates in patients after radical prostatectomy (RP) for high-risk disease seem to be unaffected. Similarly, in a large proportion of these men, a nerve-sparing procedure can be performed without a significant negative impact on surgical margin rates and with comparable potency results. Moreover, extended pelvic lymph node dissection (EPLND) contributes to accurate pathological staging with a marginal effect on perioperative morbidity. With regards to the benefits of RP on local recurrence and cure rates, realistic expectations regarding the success of RP alone or in the context of a multimodal approach should be provided during patient counseling.

M3 - SCORING: Journal article

VL - 3

SP - 173

EP - 182

JO - Ther Adv Urol

JF - Ther Adv Urol

SN - 1756-2872

IS - 4

M1 - 4

ER -